Swiss National Bank Guardant Health, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Guardant Health, Inc. stock. As of the latest transaction made, Swiss National Bank holds 239,400 shares of GH stock, worth $7.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
239,400
Previous 239,400 -0.0%
Holding current value
$7.42 Million
Previous $6.91 Million 20.6%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$16.07 - $31.84 $188,019 - $372,528
11,700 Added 5.14%
239,400 $6.91 Million
Q1 2024

May 07, 2024
BUY
$17.13 - $26.91 $125,049 - $196,443
7,300 Added 3.31%
227,700 $4.7 Million
Q4 2023

Feb 06, 2024
SELL
$21.58 - $29.5 $524,394 - $716,850
-24,300 Reduced 9.93%
220,400 $5.96 Million
Q3 2023

Nov 08, 2023
BUY
$25.8 - $39.97 $167,700 - $259,805
6,500 Added 2.73%
244,700 $7.25 Million
Q2 2023

Aug 09, 2023
BUY
$20.94 - $38.01 $588,414 - $1.07 Million
28,100 Added 13.37%
238,200 $8.53 Million
Q1 2023

May 10, 2023
SELL
$22.92 - $33.76 $275,040 - $405,120
-12,000 Reduced 5.4%
210,100 $4.92 Million
Q4 2022

Feb 08, 2023
BUY
$25.44 - $59.78 $117,024 - $274,988
4,600 Added 2.11%
222,100 $6.04 Million
Q3 2022

Nov 09, 2022
BUY
$43.66 - $61.0 $65,489 - $91,500
1,500 Added 0.69%
217,500 $11.7 Million
Q2 2022

Aug 09, 2022
BUY
$28.82 - $77.35 $337,194 - $904,994
11,700 Added 5.73%
216,000 $8.71 Million
Q1 2022

May 09, 2022
BUY
$48.25 - $100.49 $714,100 - $1.49 Million
14,800 Added 7.81%
204,300 $13.5 Million
Q4 2021

Feb 08, 2022
SELL
$88.71 - $120.43 $35,484 - $48,172
-400 Reduced 0.21%
189,500 $19 Million
Q3 2021

Nov 08, 2021
BUY
$98.77 - $132.17 $167,909 - $224,688
1,700 Added 0.9%
189,900 $23.7 Million
Q2 2021

Aug 06, 2021
BUY
$109.77 - $165.68 $1.86 Million - $2.8 Million
16,900 Added 9.87%
188,200 $23.4 Million
Q1 2021

May 07, 2021
BUY
$127.04 - $179.1 $343,008 - $483,570
2,700 Added 1.6%
171,300 $26.1 Million
Q4 2020

Feb 05, 2021
BUY
$99.96 - $135.93 $4 Million - $5.44 Million
40,000 Added 31.1%
168,600 $21.7 Million
Q3 2020

Nov 09, 2020
BUY
$80.32 - $111.8 $192,767 - $268,320
2,400 Added 1.9%
128,600 $14.4 Million
Q2 2020

Aug 05, 2020
BUY
$60.49 - $97.5 $3.22 Million - $5.2 Million
53,300 Added 73.11%
126,200 $10.2 Million
Q1 2020

May 08, 2020
BUY
$59.04 - $88.81 $100,368 - $150,977
1,700 Added 2.39%
72,900 $5.07 Million
Q4 2019

Feb 06, 2020
BUY
$59.49 - $82.78 $154,674 - $215,228
2,600 Added 3.79%
71,200 $5.56 Million
Q3 2019

Nov 12, 2019
BUY
$62.59 - $110.3 $2.3 Million - $4.05 Million
36,700 Added 115.05%
68,600 $4.38 Million
Q2 2019

Aug 02, 2019
BUY
$63.94 - $91.11 $2.04 Million - $2.91 Million
31,900 New
31,900 $2.75 Million

Others Institutions Holding GH

# of Institutions
323
Shares Held
127M
Call Options Held
844K
Put Options Held
2.38M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.17B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email